Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
What the Evidence Shows Joint pain, medically termed arthralgia, has been reported by some individuals taking Mounjaro, though it is not listed among the most common side effects in the official Summary of Product Characteristics (SmPC) or patient information leaflet
When Medicaid says no: the compounded tirzepatide alternative When Medicaid denies Mounjaro coverage, patients have three options: pay cash ($1,100+ per month), appeal the denial, or switch to compounded tirzepatide
In some cases, your insurance provider may also require you to do step therapy, which is a requirement for you to try and fail treatment with a different and less expensive medication first
Science, 205(4403), 325-327
Read Guide Peptide Sciences Alternatives: What to Use After Shutdown Post-shutdown comparison of remaining US-based suppliers on purity, pricing, and transparency
